Affimed NV (AFMD)
5.42
+0.12
(+2.26%)
USD |
NASDAQ |
May 03, 16:00
5.47
+0.05
(+0.92%)
After-Hours: 20:00
Affimed Profit Margin (Quarterly): -4.89K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.89K% |
| September 30, 2023 | -1.24K% |
| June 30, 2023 | -2.11K% |
| March 31, 2023 | -709.2% |
| December 31, 2022 | -299.7% |
| September 30, 2022 | -110.8% |
| June 30, 2022 | -265.8% |
| March 31, 2022 | -208.2% |
| December 31, 2021 | -223.3% |
| September 30, 2021 | -197.4% |
| June 30, 2021 | -193.2% |
| March 31, 2021 | 12.11% |
| December 31, 2020 | -152.6% |
| September 30, 2020 | -56.58% |
| June 30, 2020 | -417.1% |
| March 31, 2020 | -161.4% |
| December 31, 2019 | -330.9% |
| September 30, 2019 | -517.5% |
| June 30, 2019 | -258.0% |
| March 31, 2019 | 16.31% |
| December 31, 2018 | 38.51% |
| September 30, 2018 | -3.93K% |
| Date | Value |
|---|---|
| June 30, 2018 | -5.34K% |
| March 31, 2018 | -1.54K% |
| December 31, 2017 | -1.01K% |
| September 30, 2017 | -1.73K% |
| June 30, 2017 | -1.56K% |
| March 31, 2017 | -1.94K% |
| December 31, 2016 | -395.5% |
| September 30, 2016 | -1.10K% |
| June 30, 2016 | -388.4% |
| March 31, 2016 | -437.1% |
| December 31, 2015 | -378.5% |
| September 30, 2015 | -631.3% |
| June 30, 2015 | -234.6% |
| March 31, 2015 | -58.47% |
| December 31, 2014 | -6.54K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -2.17K% |
| December 31, 2013 | -55.14% |
| September 30, 2013 | -6.05K% |
| June 30, 2013 | -4.16K% |
| March 31, 2013 | -5.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.89K%
Minimum
Dec 2023
12.11%
Maximum
Mar 2021
-649.4%
Average
-258.0%
Median
Jun 2019
Profit Margin (Quarterly) Benchmarks
| InflaRx NV | -696.8K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | 30.96% |
| Immatics NV | -164.2% |
| CureVac NV | -384.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -103.7% |
| Return on Assets | -73.56% |
| Return on Invested Capital | -90.54% |
| Operating Margin (Quarterly) | -5.86K% |
| Return on Net Operating Assets | -191.9% |